Overview
Hongyu Liu practices in Beijing, China. Liu is rated as an Advanced expert by MediFind in the treatment of Squamous Cell Lung Carcinoma. Their top areas of expertise are Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC).
Their clinical research consists of co-authoring 154 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Squamous Cell Lung Carcinoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerLiu isDistinguished. Learn about Lung Cancer.
- Advanced
- GliomaLiu isAdvanced. Learn about Glioma.
- Lung AdenocarcinomaLiu isAdvanced. Learn about Lung Adenocarcinoma.
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)
- Squamous Cell Lung Carcinoma
- Experienced
- AstrocytomaLiu isExperienced. Learn about Astrocytoma.
- Brain TumorLiu isExperienced. Learn about Brain Tumor.
- Cerebral HypoxiaLiu isExperienced. Learn about Cerebral Hypoxia.
- EGFR Positive Lung CancerLiu isExperienced. Learn about EGFR Positive Lung Cancer.
- Esophageal CancerLiu isExperienced. Learn about Esophageal Cancer.
- GlioblastomaLiu isExperienced. Learn about Glioblastoma.